Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RAPID-IPF Trial
jRCT1071250015Recruiting
- Start
- May 2025
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised trial of prednisolone in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by none. Primary endpoint: 90-day mortality. Started May 2025; status: recruiting.
02
Drugs
prednisolone
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on jRCT1071250015.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT1071250015.